Brief: PledPharma Gets Approval Letter From European Patent Office

Egetis Therapeutics AB (publ)

28/03/2018 07:08

March 28 (Reuters) - PLEDPHARMA AB (PUBL)  PLED.ST :
    * PLEDPHARMA RECEIVES EUROPEAN APPROVAL OF THE COMPOSITION
OF
MATTER PATENT FOR PLEDOX® AND ALADOTE®
    * ‍EXPIRY DATE FOR PATENT IS DECEMBER, 2032.​

Source text for Eikon:  ID:nSSN7qtb 
Further company coverage:  PLED.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))